PAMELA PHELPS: Open Payments
NPI 1548599459 · MORGANTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 39 payments from 18 companies in 2025. Trend: 2023 $383 · 2024 $584 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $149 |
| Axsome Therapeutics, Inc. | 2 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| PFIZER INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Viatris Specialty LLC | 2 | $31 |
| Novo Nordisk Inc | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
Products named: REPATHA, Auvelity, XIFAXAN, TRELEGY ELLIPTA, Kerendia, YUPELRI, VOQUEZNA, LEQVIO.
Industry payments across KY — which companies pay providers there.
